Related by context. All words. (Click for frequent words.) 71 Mipomersen 71 otelixizumab 71 PDE4 inhibitor 71 tremelimumab 69 JAK inhibitor 68 HQK 68 ISIS # 67 midstage trials 67 lomitapide 67 Posiphen 67 TRO# 67 Pancreate 67 XmAb# 67 investigational humanized monoclonal antibody 67 TBC# 67 visilizumab 67 JAK2 inhibitor 67 MEK inhibitor 67 enzastaurin 67 Diamyd ® 67 orally bioavailable 66 AEG# 66 HGS# 66 oral prodrug 66 Archexin 66 mertansine 66 atacicept 66 CEQ# 66 Nuvion 66 volociximab 66 Affinitak 66 reslizumab 66 daclizumab 66 eniluracil 66 Ocrelizumab 66 Prestara 66 elotuzumab 66 GSK# [002] 66 Plicera 65 gamma secretase inhibitor 65 proteasome inhibitor 65 IAP inhibitor 65 anti CD3 antibody 65 Panzem R 65 NV1FGF 65 ocrelizumab 65 Lixivaptan 65 Canvaxin 65 muraglitazar 65 BAY #-# 65 Dapagliflozin 65 Factor VIIa 65 JAK inhibitors 65 entinostat 65 phase IIb trial 65 HCD# [002] 65 midstage clinical 65 MAXY G# 65 MAXY VII 65 PRT# 65 Symadex 65 darapladib 65 R#/MEM # 65 Behcet uveitis 65 Onconase 65 HuLuc# 65 romazarit 65 CBLC# 65 pertuzumab 65 Syntonix 65 Panzem 65 selective androgen receptor modulator 65 insulin sensitizing 65 Aflibercept 65 alvespimycin 65 HuMax EGFr 65 preclinical compounds 65 YONDELIS 65 DXL# 65 bardoxolone 65 TACI Ig 65 cilengitide 65 Aviptadil 64 GLPG# 64 targeted radiotherapeutic 64 HuMax CD4 64 tiapamil 64 MAGE A3 ASCI 64 INS# [001] 64 Balaglitazone 64 SomatoKine 64 antisense drug 64 ELND# 64 Personalized Immunotherapy 64 neratinib 64 CDP# 64 Asentar 64 sulodexide 64 incyclinide 64 Ataluren 64 figitumumab 64 ATL# [001] 64 Cinquil 64 HuMax CD# 64 RNA antagonists 64 VitiGam 64 liposomal formulation 64 cathepsin K inhibitor 64 Nanobody 64 solanezumab 64 Maxy G# 64 sodium glucose cotransporter 64 vosaroxin 64 lixivaptan 64 Phenoptin 64 erlotinib Tarceva ® 64 Maribavir 64 MGd 64 chemopreventive agent 64 Annamycin 64 ASONEP 64 Fx #A 64 OMP #R# 64 GRNCM1 64 MyVax ® 64 therapeutic monoclonal antibody 64 motesanib 64 Phase IIb clinical trials 64 small molecule activators 64 MEK inhibitors 64 riociguat 64 Zolinza 64 IAP inhibitors 64 Ceflatonin 64 Dasatinib 64 mTOR mammalian target 63 angiogenesis inhibitor 63 Corlux 63 PSN# [002] 63 glucokinase activator 63 eprotirome 63 PHX# 63 MacroGenics 63 GPR# agonist 63 ALN PCS 63 anticoagulant reversing agent 63 panitumumab Vectibix 63 senicapoc 63 epothilone 63 ATL# [002] 63 Allovectin 7 R 63 cancer immunotherapies 63 Traficet EN 63 investigational monoclonal antibody 63 THR beta agonist 63 VEGF inhibitors 63 immunotherapeutic vaccine 63 LY# [003] 63 E2F Decoy 63 EP #R 63 synthetic retinoid 63 erlotinib Tarceva 63 gastro intestinal inflammation 63 Insegia 63 alagebrium 63 ELACYT 63 ulimorelin 63 vemurafenib 63 Revlimid lenalidomide 63 OHR/AVR# 63 non alcoholic steatohepatitis 63 dexanabinol 63 Cetrorelix 63 rNAPc2 63 sorafenib Nexavar 63 oral antiviral 63 CETP inhibitor 63 phase IIb clinical 63 immune modulator 63 PXD# 63 atrasentan 63 pharmacological chaperone 63 HCV protease inhibitors 63 metaglidasen 63 lintuzumab SGN 63 axitinib 63 Aurora kinase inhibitors 63 Pimavanserin 63 SAR# [002] 63 docetaxel Taxotere R 63 Lu AA# 63 ZOLINZA 63 PSN# [001] 63 Angiocept 63 RhuDex 63 mGlu2 3 63 anti fibrotic 63 HepeX B 63 SRT# [003] 63 LAF# 63 bevacizumab Avastin ® 63 RGB # 63 CORT # 63 Azedra 63 bortezomib Velcade 63 NEUMUNE 63 urocortin 2 63 PF # [002] 63 Amplimexon 63 dexpramipexole 63 ProMune 63 Pathway Inhibitor 63 dacetuzumab 63 Bicifadine 63 compound INCB# 63 PARP inhibitors 63 histone deacetylase inhibitor 63 zanolimumab 63 multi kinase inhibitor 63 investigational drug 63 virus HCV protease inhibitor 63 PEG Interferon lambda 62 antibody MAb 62 iniparib 62 GED aPC 62 mTOR inhibitor 62 Campath ® 62 Muraglitazar 62 ganaxolone 62 torezolid phosphate 62 selective modulator 62 Excellarate TM 62 mGluR4 activation 62 JAK3 inhibitor 62 IMiDs ® 62 anticancer compound 62 Wellstat 62 IMA# 62 PNP inhibitor 62 Preclinical studies suggest 62 anticancer agent 62 Tyrima 62 Unit Dose Budesonide 62 Desmoteplase 62 Cintredekin Besudotox 62 receptor inhibitor 62 regorafenib 62 TRV# [001] 62 Aplidin 62 SNT MC# 62 immune modulating 62 JAK3 62 nicotinic alpha 7 62 psoriasis rheumatoid arthritis 62 selective inhibition 62 ONCONASE R 62 canagliflozin 62 PRTX 62 proteasome inhibitors 62 investigational hepatitis C 62 refractory gout 62 postoperative ileus 62 Amigal 62 FOLOTYN ® 62 thalidomide Thalomid 62 Lisofylline LSF 62 tafamidis 62 Revimmune 62 forodesine 62 gepirone ER 62 GALNS 62 cediranib 62 Panzem R NCD 62 Genz # 62 investigational compound 62 #beta HSD1 62 DPX Survivac 62 epothilones 62 tranilast 62 BZL# 62 Prodarsan ® 62 tasisulam 62 Androxal TM 62 gefitinib Iressa 62 Nanobody ® 62 INCB# [001] 62 Zybrestat 62 endothelin antagonist 62 IGF 1R inhibitor 62 Arimoclomol 62 cannabinor 62 varespladib 62 BRAF inhibitor 62 investigational compounds 62 Hematide ™ 62 ALN TTR 62 PARP inhibitor 62 multicenter Phase II 62 adenosine A2A 62 Vilazodone 62 Tarvacin TM 62 Davanat 62 PEG SN# 62 Syncria 62 OXi# 62 Nexavar sorafenib 62 IRX 2 62 TG# [003] 62 SAR# [004] 62 GGF2 62 insulin sensitizers 62 Arranon 62 eritoran 62 Alzhemed TM 62 AVE# 62 phase Ib 62 Epothilones 62 methylnaltrexone 62 HuMax TAC 62 Olaparib 62 RLY# 62 Viprinex 62 preclinically 62 SARMs 62 peptibody 62 alkylating agent 62 ataluren 62 Smac mimetics 62 tipifarnib 62 ADP receptor antagonist 61 IMiD 61 Hsp# inhibition 61 6R BH4 61 XL# XL# XL# XL# 61 glucagon receptor 61 renin inhibitors 61 MEK inhibitor RDEA# 61 unoprostone isopropyl 61 dasatinib Sprycel 61 Laquinimod 61 mGluR2 NAM 61 HSP# inhibitor 61 MyVax 61 FRDA 61 betrixaban 61 midstage studies 61 Exelixis compounds 61 dipeptidyl peptidase IV 61 Oglemilast 61 R#/MEM 61 IL# PE#QQR 61 integrase inhibitor 61 hedgehog pathway 61 talabostat 61 CD# monoclonal antibody 61 HGS ETR2 61 inhibit metastasis 61 liprotamase 61 ALV# 61 novel antiviral therapeutics 61 anticancer therapeutics 61 Guanilib 61 anakinra 61 FoldRx 61 IMiDs R 61 PKC# 61 L BLP# 61 MAXY alpha 61 KNS # 61 isoform selective 61 Allovectin 7 61 hypoxia inducible factor 61 CYT# potent vascular disrupting 61 immunotherapeutic approaches 61 ProSavin 61 recombinant subunit vaccine 61 Genentech Rituxan 61 SPC# [001] 61 DPP4 inhibitor 61 TolerRx 61 novel immunomodulatory 61 zileuton 61 human IgG1 monoclonal 61 Leukine 61 cMET 61 Sapacitabine 61 enzyme inhibitor 61 MyVax R 61 tanespimycin 61 SCH # 61 orally administered inhibitor 61 ENMD # 61 neuropathic pain metabolic diseases 61 NeuroVax 61 PEGylated Fab fragment 61 BiTE antibody 61 subcutaneous formulation 61 IMC A# 61 defensin mimetic antibiotic 61 Spiegelmer ® 61 MDV# 61 insulin sensitizer 61 Squalamine 61 davalintide 61 Zenapax 61 MMP inhibitors 61 Anticalin 61 HGS ETR1 61 TOCOSOL Camptothecin 61 Daclizumab 61 class mGluR5 inhibitor 61 Phenserine 61 phase IIa clinical 61 Vascular Endothelial Growth 61 DCCR 61 Atrasentan 61 SERMs 61 NPC 1C 61 ganetespib 61 Cethrin 61 Teplizumab 61 ADME properties 61 OncoVEX GM CSF 61 resolvins 61 XL# XL# 61 SGS# 61 Virulizin ® 61 mild vasodilator 61 drug GLPG# 61 adipiplon 61 BCR ABL inhibitors 61 Sym# 61 neuroprotective properties 61 Aganocide ® 61 PRX # 61 Phase Ib clinical trials 61 molecular chaperone regulation 61 thymalfasin 61 novel antibody therapeutics 61 alpha interferon 61 AEGR 61 small molecule defensin 61 bifeprunox 61 lapatinib Tykerb 61 Egrifta 61 lumiliximab 61 CCR9 antagonist 61 CTAP# Capsules 61 Octreolin 61 semagacestat 61 Xanafide 61 Friedreich Ataxia FRDA 61 DPP4 inhibitors 61 Liprotamase 61 ALK inhibitor 61 nucleotide analog 61 isradipine 61 Neo Kidney Augment 61 alogliptin 61 VEGF Trap 61 PLK1 SNALP 61 CCX# 61 exon skipping 61 Tolerx 61 Cannabinor 61 Prednisporin TM 61 intranasal insulin product 61 familial hypercholesterolemia FH 61 PDGF receptor 61 commercialize deforolimus 61 ASG 5ME 61 Anidulafungin 61 Anticalin R 61 MT#/MEDI-# 61 Vandetanib 61 IMC #F# 61 sodium glucose transporter 61 systemically administered 61 TKM ApoB 61 Gleevec imatinib mesylate 61 adrenergic regulation 61 Golimumab 61 TLR9 agonist 61 immunosuppressant drug 61 acadesine 60 Curaxin CBLC# 60 MabThera rituximab 60 KIACTA ™ 60 TPI ASM8 60 Aryplase 60 vorinostat 60 bevacizumab Avastin 60 Troxatyl 60 Tocosol Paclitaxel 60 LY# [002] 60 Albugon 60 Oral NKTR 60 Tasimelteon 60 TOCOSOL 60 Rasagiline 60 Vorinostat 60 Aurora kinase inhibitor 60 Aurexis 60 Myocet 60 immunomodulator 60 PDE# inhibitors 60 corticosteroid dexamethasone 60 radiation sensitizer 60 NOX E# 60 AZD# 60 pafuramidine 60 EC Cysteamine 60 Onglyza saxagliptin 60 alpha#beta# integrin 60 QLT# 60 MKC# MT 60 Boceprevir 60 PPARγ 60 Clonicel 60 Synavive 60 mipomersen 60 PEG PAL 60 terlipressin 60 TELINTRA 60 Vernakalant 60 Velcade bortezomib 60 therapeutic monoclonal antibodies 60 anti amnesic 60 ospemifene 60 abiraterone 60 Regado 60 oral talactoferrin 60 Genentech Roche 60 nebivolol 60 targeting CD# 60 dirucotide 60 Hedgehog inhibitor 60 dirucotide MBP# 60 Tykerb lapatinib 60 Romiplostim 60 JAK1 60 acetonide FA 60 Tarceva TM 60 Interferon alpha 60 rilonacept 60 Ostarine 60 Diamyd R 60 REGN# 60 HCV NS5B polymerase 60 CINQUIL 60 Pyridorin 60 immunological diseases 60 BRAF inhibitors 60 predictive biomarkers 60 Rigel R# 60 A3 adenosine receptor 60 PD LID 60 novel therapeutic antibodies 60 Phase Ib study 60 NIC5 60 Deforolimus 60 StemEx R 60 RG# [001] 60 protein kinase inhibitor 60 mGluR2 positive 60 dasatinib Sprycel ® 60 Vidaza azacitidine 60 anticancer therapy 60 RhuDex R 60 flavopiridol 60 GRN# 60 vivo validation 60 RNAi therapeutic targeting PCSK9 60 AQ4N 60 Telintra 60 obatoclax 60 personalized immunotherapy 60 IMC #B 60 Arcalyst 60 ICA # 60 Enzastaurin 60 HCV protease 60 Curaxin 60 pomalidomide 60 sorafenib tablets 60 CD# CEA 60 fostamatinib 60 lintuzumab 60 multiple myeloma MM 60 BCR ABL inhibitor 60 Amrubicin 60 schizophrenia CIAS 60 PrevOnco 60 Zalbin 60 Factor Xa inhibitor 60 Promacta 60 DFMO 60 investigational oral 60 Telcyta 60 maribavir 60 aleglitazar 60 olaparib 60 Tamibarotene 60 aerosolized AAT 60 trastuzumab DM1 T DM1 60 BHT DNA 60 peptidic compound 60 basal insulin analogue 60 anti CD3 monoclonal 60 NP2 Enkephalin 60 Phase IIb trials 60 Zerenex 60 kidney urologic 60 albiglutide 60 Neo Kidney Augment ™ 60 poly ADP ribose polymerase 60 Zoraxel 60 Tavocept 60 hypoxia selective 60 Mycograb 60 Enzyme Replacement Therapy 60 SGLT2 60 Carfilzomib 60 DermaVir Patch 60 MYDICAR ® 60 tubulin inhibitor 60 generation purine nucleoside 60 #ME# 60 mGluR5 antagonists 60 Aurora kinase 60 Kosan dependence 60 Chemokine 60 sodium thiosulfate STS 60 diabetic nephropathy 60 STEDESA 60 targeted antifolate 60 Xinlay 60 Phase 2b clinical trials 60 PF # [001] 60 Leukine ® 60 diarrhea predominant irritable 60 hyperphenylalaninemia HPA due 60 Cloretazine 60 systemic RNAi therapeutic 60 Homspera TM 60 baminercept 60 selective androgen receptor modulators 60 adecatumumab MT# 60 Phase #b/#a trial 60 receptor tyrosine kinase inhibitor 60 oral dihydropyrimidine dehydrogenase DPD 60 IMiDs 60 CXB# 60 Aganocide 60 SGLT2 inhibitors 60 Aurograb 60 orally dosed 60 Vitaxin 60 cetuximab Erbitux 60 inhaled formulation 60 FTIs 60 Marcadia 60 Protectan CBLB# 60 Prodarsan 60 CR# vcMMAE 60 GAMMAGARD 60 Cardio Vascu Grow 60 regadenoson 60 experimental hepatitis C 60 XL# anticancer compounds 60 Sulonex 60 Trofex 60 Pervasis 60 Phase #b/#a 60 HCV protease inhibitor 60 compound PMX # 60 Allovectin 7 ® 60 biologic therapy 60 lupus nephritis 60 Certolizumab pegol 60 humanized anti 60 GW# [003] 60 Ambrx 60 Fabry Disease 60 PEGylated 60 myelofibrosis polycythemia vera 60 OncoVex 60 relapsed multiple myeloma 60 Triolex 60 Fc fusion protein 60 DEB# 60 uric acid lowering 59 pharmacodynamic markers 59 nalbuphine ER 59 Sphingomab TM 59 Galenea 59 AERx iDMS 59 angiogenesis inhibition 59 SUTENT ® 59 novel VDA molecule 59 Elvitegravir 59 pradefovir 59 safinamide 59 Bezielle 59 TYZEKA 59 BioNumerik 59 PSMA ADC 59 Ophthotech 59 CRD5 59 Lisofylline 59 dimebon 59 small molecule thrombopoietin 59 MGCD# [001] 59 deforolimus 59 non nucleoside inhibitor 59 Menerba 59 ApoB SNALP 59 incretin 59 Chrysalin 59 Azacitidine 59 ThGRF 59 EVIZON TM 59 OncoVEX 59 ostarine 59 peroxisome proliferator activated 59 histone deacetylase HDAC inhibitors 59 Pradefovir 59 faropenem 59 Bryostatin 59 P#X# antagonist 59 nucleoside analog 59 CB2 selective receptor agonist 59 cholesteryl ester transfer 59 Tarvacin 59 Darapladib 59 NTDDS 59 TLR8 agonist 59 beta HSD1 59 KRN# 59 cariprazine 59 mapatumumab 59 DU #b 59 Darusentan 59 oral JAK#/JAK# inhibitor 59 bafetinib 59 NeuVax 59 Ostarine ™ 59 midstage clinical trials 59 Degarelix 59 SILENOR 59 Intarcia 59 novel peptide 59 oral anticancer 59 rBChE 59 Pertuzumab 59 ZADAXIN ® 59 BioSeek 59 phase III isavuconazole 59 vinca alkaloid 59 optimal dosing regimens 59 ANAVEX #-# [003] 59 eltrombopag 59 tyrosine kinase inhibitor 59 metreleptin 59 aflibercept 59 Addrenex 59 telomerase therapeutic 59 EndoTAG TM -1 59 pharmacodynamic effects 59 talactoferrin 59 Serdaxin 59 PI3K/Akt pathway inhibitor 59 temsirolimus 59 investigational protease inhibitor 59 Interferon beta 59 non nucleoside 59 dutogliptin 59 Omacetaxine 59 Cimzia R 59 anticancer activity 59 APD# 59 Preos 59 GSK # 59 Alnylam RNAi 59 rhIGF-I/rhIGFBP-3 59 PrevOnco ™ 59 refractory chronic lymphocytic 59 SCIB1 59 Nexavar ® 59 IV Busulfex 59 siRNA therapeutic 59 Cimzia TM 59 Saxagliptin 59 rALLy clinical trial 59 Poly ICLC 59 proteasome inhibitor bortezomib 59 Erbitux cetuximab 59 registrational trial 59 Neurimmune 59 LymphoStat B TM 59 CTLA 4 59 depsipeptide 59 tolerability pharmacokinetics 59 siRNA therapeutics 59 Clofarabine 59 registrational 59 blood clot preventer 59 Bortezomib 59 novel anticancer 59 ruxolitinib 59 OvaRex ® MAb 59 luteinizing hormone releasing 59 nitric oxide donating 59 chronic thromboembolic pulmonary 59 oral Azacitidine 59 phase IIa 59 CMV vaccine 59 Cloretazine ® 59 TriRima 59 Denufosol 59 preclinical efficacy 59 relapsed leukemia 59 anticancer therapies 59 favorable pharmacokinetic profile 59 sargramostim 59 therapeutic peptide 59 teriflunomide 59 diabetic neuropathic pain 59 huC# DM4 59 PDE# 59 LymphoStat B 59 immunotherapeutic 59 antisense inhibitors 59 vidofludimus 59 molecular imaging radiopharmaceutical 59 neurotrophic factor 59 Prodarsan R 59 ixabepilone 59 Vorapaxar 59 TRIOLEX 59 molecularly targeted 59 kallikrein 59 pan HDAC inhibitor 59 OMP #M# 59 HepeX B TM 59 FOLFOX chemotherapy 59 PS# [001] 59 Fibrillex TM 59 ALN TTR# 59 canakinumab 59 evaluating tivozanib 59 pregabalin Lyrica 59 MTP inhibitor 59 Canvaxin TM 59 cyclophilin inhibitors 59 rFVIIIFc 59 Iloperidone 59 mTOR inhibition 59 Elisabeth Lindner CEO 59 Memryte 59 Atiprimod 59 CCR5 antagonist 59 severe hypercholesterolemia 59 brostallicin 59 dalbavancin 59 oral salmon calcitonin 59 adalimumab Humira 59 CD3 monoclonal antibody 59 omecamtiv mecarbil 59 vascular disrupting agents 59 Naproxcinod 59 Temsirolimus 59 LSI #P 59 pegylated interferons 59 menadione 59 Androxal ® 59 Cushing Syndrome 59 vascular disrupting agent 59 TRIOLEX HE# APOPTONE HE# 59 prostone 59 Gattex 59 R sorafenib tablets 59 cetuximab Erbitux R 59 immunotherapeutic agent 59 BXT # 59 BENLYSTA ® 59 custirsen 59 TREANDA 59 immunosuppressive medication 59 CDDO Im 59 beta 1a 59 delta gamma agonist 59 RhuDex ® 59 pharmacodynamic profile 59 Imprime PGG 59 elinogrel 59 Gastrotech 59 NeuroVax TM 59 investigational pan BCR 59 Herceptin trastuzumab 59 Yervoy 59 RNAi therapeutic targeting 59 Milnacipran 59 postoperative ileus POI 59 romidepsin novel 59 CYT# 59 Plasmin 59 pharmacodynamic properties 59 rxRNA 59 midstage clinical trial 59 Gemzar gemcitabine 59 Technosphere Insulin 59 romidepsin 59 HIV protease inhibitors 59 CCR5 inhibitor 59 haematological cancers 59 oxypurinol 59 preclinical 59 Sphingomab 59 insulin analogs 59 tramiprosate ALZHEMED TM 59 novel peptides 59 fipamezole 59 Zarnestra 59 Diamyd r vaccine 59 MKC# MKC# PP 59 Adnectin 59 homozygous familial hypercholesterolemia 59 castrate resistant prostate cancer 59 Pagoclone 59 mGluR4 59 Vidofludimus 59 ZFP Therapeutic 59 anidulafungin 59 Trimesta 59 cardio renal 58 PDX pralatrexate 58 Surfaxin LS 58 Vicriviroc 58 recurrent metastatic ovarian cancer 58 Zenyaku Kogyo 58 PREOS 58 Initiates Clinical 58 cysteamine bitartrate 58 Ophena 58 Gleevec resistant 58 trastuzumab DM1 58 ularitide 58 GLYX 58 teduglutide 58 standard chemotherapy regimen 58 HCV nucleoside polymerase inhibitors 58 CDK inhibitors 58 Tezampanel 58 Lenocta 58 candidate CRLX# 58 Sudhir Agrawal D.Phil 58 cangrelor 58 ATL/TV# 58 elesclomol 58 Motavizumab 58 lipid particle 58 etanercept Enbrel 58 dimebon latrepirdine 58 Betrixaban 58 trastuzumab Herceptin R 58 MyVax personalized immunotherapy 58 oral Factor Xa 58 Anacetrapib 58 HGS ETR1 mapatumumab 58 neuroprotectant 58 oral ghrelin agonist 58 Fodosine 58 generation antisense inhibitor 58 TRX1 58 Alinia 58 humanized antibody 58 galiximab 58 immune modulatory 58 orBec 58 Capesaris 58 ACZ# 58 Stedivaze 58 ALN HPN 58 TOCOSOL Paclitaxel 58 PTP 1B 58 Dynogen 58 prostaglandin D2 58 tezampanel 58 humanized monoclonal antibody 58 Safinamide 58 Actemra tocilizumab 58 SGLT inhibitors 58 Vegenics 58 Acapodene 58 engineered RAP peptides 58 KAI Pharmaceuticals 58 ImmunoGen TAP technology 58 PI3 kinase inhibitors